iRadimed Q3 Adj. EPS $0.23 Beats $0.17 Estimate, Sales $10.90M Beat $10.40M Estimate
iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.17 by 35.29 percent. This is a 109.09 percent increase over earnings of $0.11 per share from the same